Medical Condition News

RSS

Study: Increased acetylation of histones promotes fear extinction in mice

The targeted modulation of gene activity and cellular signaling pathways could provide a new approach to the treatment of fear and anxiety states according to the recent findings of a project sponsored by the Austrian Science Fund FWF.

29 Sep 2015

Research posters support utility of EKF’s PointMan DNA enrichment technology for rapid detection of lung cancer mutations

EKF, announces two research posters supporting application of PointMan™ DNA enrichment technology, for rapid and sensitive detection of lung cancer mutations.

From EKF Diagnostics 29 Sep 2015

Johns Hopkins study highlights need for effective postpartum interventions for women with pregnancy complications

Citing an analysis of more than 26,000 Maryland Medicaid claims, Johns Hopkins researchers report evidence that poor women with recent complications during their pregnancies are using the emergency room at higher rates after delivery and may not be getting the postpartum care and follow-up they need to prevent further health problems.

29 Sep 2015

New global educational initiative helps men identify symptoms of advanced prostate cancer

Although prostate cancer may exhibit no symptoms in its early stages, symptoms like severe or unexplained pain, difficulty walking or climbing stairs, difficulty sleeping or loss of bladder control may emerge when the disease advances as a signal to men to take action with their doctors.

29 Sep 2015

UAB awarded $9.4 million grant to lead a trial to improve blood pressure in the U.S Black Belt

The University of Alabama at Birmingham has been awarded a $9.4 million grant to lead a trial in an effort to improve blood pressure in the Black Belt of the United States.

29 Sep 2015

New drug works better than current treatments for advanced kidney cancer

A new drug has been found superior to current treatments in slowing the growth of advanced kidney cancer in patients who became resistant to the first-line therapies that had kept it in check, according to results from a clinical trial led by Dana-Farber Cancer Institute.

29 Sep 2015

Researchers find way to predict occurrence of some cardiac arrhythmias

Researchers have discovered how to predict some cardiac arrhythmias several steps before they even occur. It's a finding that could lead to an improved cardiac device, with equipment designed to detect when arrhythmias are about to occur and then act to prevent them.

29 Sep 2015

Collaborative program aims at reducing cancer burden among Hispanic/Latinos receives grant from NCI

A collaborative program aimed at reducing the burden of cancer among Hispanic/Latinos in San Diego and Imperial counties through research and community outreach has received a $13 million grant from the National Cancer Institute, part of the National Institutes of Health. The five-year grant renews funding for a partnership started in 2008 between San Diego State University and Moores Cancer Center at UC San Diego Health.

29 Sep 2015

The Center for Bariatric Surgery receives MBSAQIP accreditation for safe, high-quality bariatric patient care

The Center for Bariatric Surgery has earned certification for adult and teen weight loss surgery under the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) which sets standards for safe, high-quality bariatric patient care.

29 Sep 2015

Endocrine-disrupting chemical exposure linked to increased risk of diabetes and obesity

Emerging evidence ties endocrine-disrupting chemical exposure to two of the biggest public health threats facing society - diabetes and obesity, according to the executive summary of an upcoming Scientific Statement issued today by the Endocrine Society.

29 Sep 2015

UT Southwestern Medical Center geneticist named 2015 recipient of Pearl Meister Greengard Prize

UT Southwestern Medical Center geneticist Dr. Helen Hobbs is the 2015 recipient of the prestigious Pearl Meister Greengard Prize. The prize recognizes Dr. Hobbs' research, which advances understanding of heart disease and other complex disorders.

29 Sep 2015

New targeted therapy shows promise against small cell lung cancer

Small cell lung cancer (SCLC) is an aggressive disease that is difficult to treat and is frequently only diagnosed when it has spread to other parts of the body (metastasised). Five-year survival rates in SCLC, which accounts for about 14% of all lung cancers, are very low, at only six percent. But today US researchers will present two novel findings with important implications for treatment at the 2015 European Cancer Congress.

29 Sep 2015

Promising drug candidate for chronic intractable itch

If you have an itch, you have to scratch it. But that’s a problem for people with a condition called “chronic intractable itch,” where that itchy sensation never goes away—a difficult-to-treat condition closely associated with dialysis and renal failure.

28 Sep 2015

Philip Chapper & Co to showcase new partner products at Europe’s largest pharmaceutical trade fair

Philip Chapper & Company Ltd, a UK company with over 40 years’ experience within medical supplies, is to showcase innovative products from new suppliers at the industry’s largest European trade fair.

28 Sep 2015

Air Liquide Healthcare launches a website dedicated to sleep apnea

On the occasion of the ERS's (European Respiratory Society) annual international seminar, which is held in Amsterdam from 27 to 30 September, Air Liquide Healthcare is launching an innovative and educational information website dedicated to sleep apnea.

28 Sep 2015

ILUVIEN continues to show positive results in Europe

Alimera Sciences Limited, the European subsidiary of Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced the availability of real world data from 28 injections of ILUVIEN (Fluocinolone Acetonide 190 micrograms intravitreal implant in applicator) in Europe, presented in a review paper authored by Fahd Quhill, Consultant Ophthalmologist, Department of Ophthalmology, Royal Hallamshire Hospital, Sheffield, South Yorkshire, U.K.

28 Sep 2015

FDA accepts Braeburn's resubmission of Probuphine NDA for review

Braeburn Pharmaceuticals, an Apple Tree Partners company, today announced that the U.S. Food and Drug Administration has accepted Braeburn's resubmission of the Probuphine New Drug Application (NDA) for review and set February 27, 2016 as the target date for Agency action.

28 Sep 2015

Clinical trial data from Array BioPharma's binimetinib and encorafenib presented at ECC 2015

Clinical trial results from Array BioPharma's wholly-owned MEK inhibitor, binimetinib, and BRAF inhibitor, encorafenib, were presented this weekend at the European Society of Medical Oncology's annual European Cancer Conference (ECC). At the meeting, preliminary data were shared from both a Phase 2 combination trial of binimetinib and encorafenib in BRAF-mutant melanoma patients (LOGIC2) and a Phase 1b/2 combination trial of binimetinib and ribociclib (Novartis, LEE011), a CDK4/6 inhibitor in NRAS-mutant melanoma patients.

28 Sep 2015

New app may help athletes identify possible concussion symptoms

Sports-related concussions have sparked a national debate, multiple lawsuits and new concussion-management protocols in the NCAA and NFL in the last few years. Despite all the attention to concussion and its risks, many student-athletes either don't recognize the signs of concussion -- or won't report them if they do.

28 Sep 2015

Occupational exposure to metalworking fluid associated with irreversible lung disease

Occupational exposure to fluid commonly used in metal machining operations may be related to a rare, irreversible lung disease, according to research presented at the European Respiratory Society's (ERS) International Congress today (28 September, 2015).

28 Sep 2015

Medical Condition News

Study: Increased acetylation of histones promotes fear extinction in mice

Research posters support utility of EKF’s PointMan DNA enrichment technology for rapid detection of lung cancer mutations

Johns Hopkins study highlights need for effective postpartum interventions for women with pregnancy complications

New global educational initiative helps men identify symptoms of advanced prostate cancer

UAB awarded $9.4 million grant to lead a trial to improve blood pressure in the U.S Black Belt

New drug works better than current treatments for advanced kidney cancer

Researchers find way to predict occurrence of some cardiac arrhythmias

Collaborative program aims at reducing cancer burden among Hispanic/Latinos receives grant from NCI

The Center for Bariatric Surgery receives MBSAQIP accreditation for safe, high-quality bariatric patient care

Endocrine-disrupting chemical exposure linked to increased risk of diabetes and obesity

UT Southwestern Medical Center geneticist named 2015 recipient of Pearl Meister Greengard Prize

New targeted therapy shows promise against small cell lung cancer

Promising drug candidate for chronic intractable itch

Philip Chapper & Co to showcase new partner products at Europe’s largest pharmaceutical trade fair

Air Liquide Healthcare launches a website dedicated to sleep apnea

ILUVIEN continues to show positive results in Europe

FDA accepts Braeburn's resubmission of Probuphine NDA for review

Clinical trial data from Array BioPharma's binimetinib and encorafenib presented at ECC 2015

New app may help athletes identify possible concussion symptoms

Occupational exposure to metalworking fluid associated with irreversible lung disease

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News